| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director | Sr MD Gen Counsel &Corp Secr
2 companies
Cronin Kathleen M serves as a Sr MD Gen Counsel &Corp Secr at CME and has filed Form 4s across 2 companies. Across recent SEC filings that breaks down to 0 buys and 8 sells. Those positions are worth an estimated $11.5M at current prices.
The biggest single holding is CME (~$11.1M) as Sr MD Gen Counsel &Corp Secr. The recent filings there lean toward selling, a net 36,291 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 11, 2022 | CME Cme Group Inc. | Sr MD Gen Counsel &Corp Secr | Sell | 4,000 | $227.15 | $908,612.00 | -9.0% | -12.0% | -21.5% | |
| Jun 14, 2021 | CME Cme Group Inc. | Sr MD Gen Counsel &Corp Secr | Sell | 4,092 | $215.31 | $881,048.52 | -8.8% | -12.3% | -6.5% | |
| Dec 14, 2020 | CME Cme Group Inc. | Sr MD Gen Counsel &Corp Secr | Sell | 6,208 | $178.41 | $1,107,569.28 | -12.6% | - | - | |
| Dec 13, 2019 | CME Cme Group Inc. | Sr MD Gen Counsel &Corp Secr | Sell | 3,371 | $204.12 | $688,088.52 | -7.5% | - | - | |
| May 21, 2019 | CME Cme Group Inc. | Sr MD Gen Counsel &Corp Secr | Sale+OE | 4,960 | $186.69 | $925,982.40 | -10.1% | - | - | |
| Mar 14, 2019 | CME Cme Group Inc. | Sr MD Gen Counsel &Corp Secr | Sale+OE | 8,340 | $167.54 | $1,397,291.45 | -9.4% | - | - | |
| May 31, 2018 | CME Cme Group Inc. | Sr MD Gen Counsel &Corp Secr | Sale+OE | 5,320 | $164.75 | $876,470.53 | -12.1% | - | - |